Advanced growth hormone research complex formulated to support studies involving recovery, sleep quality, lean mass support, muscle preservation, and healthy aging pathways.

CJC-1295 is a long-acting growth hormone releasing hormone (GHRH) analog studied for its potential to support sustained growth hormone signaling, while Ipamorelin is a selective growth hormone secretagogue researched for its ability to stimulate GH release with targeted receptor activity.

Together, this combination is widely researched for synergistic effects on recovery, lean mass support, metabolic function, and overall performance-related pathways.